Dive Brief: Sanofi has found a new head of research and development in Houman Ashrafian, who currently serves as a scientific advisor at SV Health Investors. His s...

Dive Brief: Sage Therapeutics, reeling from a regulatory decision that will sharply curtail the potential of its newest medicine, is slashing jobs, pausing some ea...

The pharmaceutical industry’s counterattack against Medicare’s new drug pricing powers widened Friday with AstraZeneca joining several of its drugmaker peers in suing...

Pharmaceutical giant Merck & Co. has begun late-stage testing of a cholesterol pill it hopes could be its next big heart medicine. The company on Friday said it ...

A closely watched, experimental Roche medicine may be helping lung cancer patients live longer, spurring renewed optimism about an emerging class of immunotherapy tre...

Dive Brief: Neumora Therapeutics on Friday filed plans for an initial public offering, one month after announcing it would soon begin late-stage testing for a new ...

Dive Brief: A drug combination involving Gilead’s antibody medicine Trodelvy shrank or eliminated tumors in just over half of the lung cancer patients who received...

One of Merck & Co.’s already marketed drugs has generated positive results in a large clinical trial testing it in patients with a hard-to-treat form of kidney ca...

Dive Brief: Moderna on Thursday said the updated COVID shot it’s preparing ahead of a fall vaccination campaign can neutralize two new coronavirus strains, among t...

Dive Brief: After years of fits and starts, Ipsen won Food and Drug Administration approval to sell the first treatment for a rare disease known as fibrodysplasia ...